Profile disclosures
Strategy and analysis
Novo Nordisk’s business strategy and the company’s commitment to sustainable development is described under Vision and strategy and the Novo Nordisk Way of Management.
In their welcome letter in the Annual Report 2007, Novo Nordisk’s president and CEO and the Chairman of the Board elaborate on the company’s position and challenges going forward.
Current key risks to Novo Nordisk’s business are disclosed in the Annual Report and the Form 20F, submitted to the SEC.
Organisational profile
Novo Nordisk is a focused healthcare company headquartered in Denmark. With market presence in 179 countries, and R&D and production facilities spanning five continents, the company’s global reach is expanding.
See a short description of the company.
Report profile
Novo Nordisk reports annually on sustainability performance in the Annual Report. The fiscal year is the calendar year. The Annual Report 2007 is published in February 2008 for approval by shareholders at the Annual General Meeting in March.
See more about the company’s reporting.
Report scope and boundary
Novo Nordisk’s non-financial reporting follows the accountability standard, AA1000 Framework. It states that reporting must provide a complete, accurate, relevant and balanced picture of the organisation’s approach to and impact on society.
See more about the company’s assurance mechanisms and accounting policies.
